Please select the eligibility criteria that correspond to the clinical trial below.
Title: Clinical Research on the Efficacy and Safety of East-West Collaborative Treatment Using NSAIDs and BV on Chronic Cervical Pain; A Randomized, Controlled, Parallel, Pilot Study
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of east-west collaborative treatment using bee venom acupuncture and NSAIDs on pain intensity, functional status and quality of life of patients with chronic cervicalgia


Options:
A: Inclusion Criteria:

* over 18
* present myofascial trigger points in trapezius muscle

Exclusion Criteria:

* to be under anti-inflammatory, analgesic, anticoagulant, muscle relaxant or antidepressant medication at the start of the study or one week before it (Simons, 2004)
* to suffer from fibromyalgia syndrome, or to have any contraindication to conservative or invasive physiotherapy (infection, fever, hypothyroidism, fear of needles, wounds in the area of the puncture, metal allergy, cancer, systemic disease) (Baldry, 2005).
B: Inclusion Criteria:

* age between 18 and 65 years
* nonspecific, uncomplicated, chronic neck pain over 3 months
* volunteer can read and write in Korean, providing written informed consent

Exclusion Criteria:

* exhibited abnormalities on neurological examination
* radicular pain
* serious spinal disorders including malignancy, vertebral fracture, spinal infection or inflammatory spondylitis
* other chronic diseases that could affect or interfere with the therapeutic outcomes including cardiovascular disease, diabetic neuropathy, active hepatitis, fibromyalgia, rheumatoid arthritis, dementia or epilepsy
* previous spinal surgery or scheduled procedures during the study
* painful conditions induced by traffic accidents
* a substantial musculoskeletal problem generating pain from an area other than the neck
* conditions for which administration of BVA might not be safe including clotting disorders, administration of an anticoagulant agent, pregnancy and seizure disorders
* a documented hypersensitive reaction to previous BVA treatments, bee stings or insect bites
* positive reaction observed during a skin hypersensitivity test
* severe psychiatric or psychological disorders
* current use of corticosteroids, narcotics, muscle relaxants or herbal medicines to treat neck pain or any medication considered inappropriate by the investigator
* pending lawsuits or receipt of compensation due to neck pain.
C: Inclusion Criteria:

* A clinically relevant MFTrP of the upper Trapezius musculature
* Self-reported pain of ≥3 on an eleven-point numerical pain rating scale (NRS-101).
* BMI less than 31

Exclusion Criteria:

* a history of chronic, systemic pathology (e.g. hemophilia)
* pre-existing neck/shoulder pathology/surgical procedures,
* clinical depression
* health-related legal action
* pregnant
* anti-inflammatory and/or chronic pain medication
* had received dry needling for a shoulder/neck disorder within 6 months prior to the study (to raise the level of patient naiveté) suffered from needle phobia
D: Inclusion Criteria:

- presence of Chronic neck pain

Exclusion Criteria:

* Cancer
* Spinal infection
* ankylosing spondylosis
* myelopathy
* moderate hypertension or more
* serious mental disease
* other skeletomuscular disease
* history of operation or acupuncture treatment about spinal disease

Answer: B